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Abstract
Aims The aim of our study was to estimate the overall rate of first hospitalizations for diabetic foot (DF) regardless of the out-
come in amputations, as well as the mortality rate with their determinants in the period 2012–2016 in Piedmont Region in Italy.
Methods The study included all the subjects registered in the Regional Diabetes Registry and alive as at January 1, 2012. 
DF cases were identified by record linkage with the regional hospital discharge database. Incident cases of diabetic foot 
were followed up for mortality.
Results The 5-year rates were 1762, 324, and 343 × 100,000 patients for first hospitalization without amputations, with 
major amputations, and with minor amputations, respectively. Patients not undergoing amputations were more than 70% of 
the cohort. Patients with the more severe stages of diabetes and those with low education were at higher risk of each type of 
hospitalization. The risk of death during a mean follow-up of 2.5 years was about 16, 18, and 30% among patients without 
amputations, with major amputations, and with minor amputations, respectively. Males, insulin-treated patients, those affected 
with severe diabetes complications, particularly on dialysis, and those with lower levels of education were at higher risk.
Conclusions The heavier burden of DF on hospitalizations is due to cases without amputation, a condition that is seldom 
considered in the diabetes literature. The severity of diabetes, preexisting complications, and low educational levels are 
associated with both first hospitalization and subsequent survival at any level of severity of DF.
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Introduction
Ulcers as well as both major and minor amputations repre-
sent the main outcomes in the diabetic foot (DF) syndrome 
[1–6].
DF ulcerations are characterized by high recurrence: 
About 40% of the patients with a healed ulcer have a recur-
rence within 1 year, whereas 65% at 5 years [1].
The presence of DF ulcerations is characterized by poor 
prognosis: 85% of amputations stem from an ulcer [7].
Notably, the presence of an ulcer in diabetic patients is con-
sidered an independent risk factor for cardiovascular mortality 
at 10 years [8, 9], and in patients with a new ulcer, the 5-year 
survival has been calculated to be 50–60% that represents a 
lower life expectancy than that in some common neoplasms.
The amputation rate cannot be considered as good marker 
of the quality of clinical care as, theoretically, the most 
appropriate end point would be the complete healing with-
out amputation, even if this result is in many cases difficult 
to achieve [10].
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Although if it is relatively simple to get from the hospi-
tal discharge sheets (HDSs) the number of hospital admis-
sions related to major and minor amputations, the amount 
of admissions due to DF that do not result in amputation is 
difficult to calculate, and it is even more difficult to describe 
the polymorphic vascular/neurological/infective compo-
nents typical of the ulcerative diseases and of the diabetic 
neuroarthropathy.
The principal objective of this study was to estimate, in a 
large Italian Region, the overall rate of first hospitalizations 
for DF regardless of the outcome in amputations, the mortal-
ity rate following the hospitalization, and their determinants 
in the period 2012–2016.
Research design and methods
Study population
The study included all the subjects registered as affected by 
diabetes mellitus in the Regional Diabetes Registry (RDR) 
of the Piedmont Region (4,400,000 inhabitants in North-
western Italy) and alive as at January 1, 2012. RDR records 
all subjects who obtained exemption from payment of drugs, 
diabetes devices, and laboratory testing due to a confirmed 
diagnosis of diabetes mellitus [11].
The type of diabetes was retrieved from the RDR. The 
severity of the disease was estimated from the prescribed 
therapy as well as from the presence of cardiovascular 
disease (CVD) or chronic kidney failure (CKF) [12, 13]. 
Data on therapy were retrieved via record linkage with the 
regional drug prescriptions database. Treatment was cat-
egorized as: no drug therapy, oral antidiabetics (separately 
secretagogue or not secretagogue drugs), and insulin (sepa-
rately short acting or long acting). Patients prescribed both 
insulin and oral antidiabetics were included in the “insu-
lin treatment” category. A patient was defined as being on 
therapy if he/she had filled at least two drug prescriptions in 
the previous 12 months [12]. Data on existing cardiovascular 
disease (CVD) were obtained by record linkage with the 
regional hospital discharge database, which contains data on 
all hospitalizations of Piedmont residents wherever they may 
have been hospitalized in Italy. All patients discharged from 
hospital in the previous 5 years with a primary or secondary 
diagnosis of coronary heart disease (ICD 9-CM: 410–414) 
or cerebrovascular disease (ICD 9-CM: 430–438) were 
defined as having CVD. Similarly, we considered as affected 
from CKF all the patients who had a dialytic treatment in the 
previous 5 years [12].
Educational level for each individual was obtained by 
record linkage with the 2011 National Census and was clas-
sified into three levels: high (university or high school), 
medium (middle school), and low (primary school or no 
formal education).
Diabetic foot definition and classification
DF cases were identified through a deterministic record link-
age between the cohort of persons with diabetes and the 
regional hospital discharge database. Hospital discharges 
with DRGs (24th version) or ICD-9-CM codes reported in 
Table 1 were considered as having a DF, classified according 
to three different levels of severity: hospitalization without 
amputations, with minor (below ankle) amputations, and 
with major (above ankle) amputations [13].
Individuals without a previous hospitalization for the 
causes reported in Table 1 during the period 2007–2011 
were considered as incident cases and were included in the 
study from January 1, 2012, to December 31, 2016. Patients 
who were classified in more than one level of severity were 
included separately in every level (i.e., a patient with an 
evolving level of severity can be included in different lev-
els of severity, therefore contributing to different levels of 
incidence).
Outcomes
Patients considered as incident cases of DF were followed 
up for mortality. Information on death (or transfer out of 
Piedmont) was obtained by record linkage with the Unique 
Regional Archive of residents covered by the regional health 
system.
Statistical analysis
The crude (cumulative) incidence of DF was calculated by 
dividing the number of patients with diabetes classified in 
the three levels of severity by the total number of residents in 
Piedmont in the period 2012–2016. Incidence was standard-
ized by age using Poisson regression, and 95% confidence 
intervals were calculated.
The start of follow-up was defined as the date of inci-
dence (i.e., the first hospital admission) and ended at the 
date of death or transfer out of Piedmont or December 31, 
2016, whichever came first. We defined as lost to follow-
up patients who moved out of the region during the study 
period. Days of follow-up were calculated as the difference 
between the incidence date and the date of the event under 
study, loss to follow-up, death, or December 31, 2016. Cox 
regression was used to estimate adjusted hazard ratios (HR), 
after testing for proportionality of risks, and 95% confi-
dence intervals were calculated. Statistical analyses were 
performed using SAS version 9.4 and STATA version 13.
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Results
As of January 1, 2012, we identified 246,877 residents in 
Piedmont with diagnosed diabetes. Within this cohort, from 
2012 to 2016, we identified 5999 incident cases (i.e., first 
hospitalization) of DF: 848 cases of major lower limb ampu-
tations (65.8% men), 801 of minor amputations (69.8% men), 
and 4350 without amputation (61.3% men), thus resulting 
in a 5-year crude incidence of, respectively, 343.5 × 100,000 
(IC 95% 320.4–366.6), 324.4 × 100,000 (IC 95% 302–347), 
and 1762.1 × 100,000 (IC 95% 1709.7–1814.4). Table 2 
reports the 5-year, age-adjusted, cumulative incidence of 
DF by selected clinical characteristics and educational level 
in the two genders. Among men, considering the three levels 
of severity together, the incidence of DF complication was 
3102 × 100,000, i.e., 3% 5-year chance of developing this 
complication. As expected, the incidence was much higher 
for DF without amputation compared to the two other more 
severe conditions. Incidence was higher for type 1 diabetes, 
but the difference with type 2 was significantly different only 
for major amputations. Incidence increased with increasing 
severity of the disease as detected either by therapy, or previ-
ous cardiovascular disease or dialytic treatment: DF without 
amputations was nearly five times higher among insulin-
treated patients compared to those with no drug therapies, 
and this difference rose to ten times when considering major 
amputations. The highest incidence of DF, for each of the 
three levels of severity, was recorded among patients under-
going dialytic treatment. DF complications were higher 
among low-educated patients, particularly for amputations 
(both minor and major).
Incidence among women was lower than among men, 
being 1775 × 100,000 (three levels together), i.e., 1.7% 
5-year chance of developing a DF. No statistically sig-
nificant difference was evident between types of diabetes, 
while, similarly to men, the incidence of the complications 
rose with the severity of the disease, being the highest in 
insulin-treated patients and in those on dialysis, for whom 
the risk of major amputations was more than twenty times 
higher than that in patients not on dialysis. Differently from 
men, the incidence of DF was higher among low-educated 
women only in the “no amputation” group, while no differ-
ences were evident in case of amputations.
During the 2.5-year mean period of follow-up from the 
onset of a DF complication, 1121 deaths occurred. Not 
surprisingly, mortality increased with increasing sever-
ity of DF, being 165.5 × 1000 in patients without amputa-
tions, 183.5 × 1000 in patients with minor amputations, and 
299.0 × 1000 in those with major amputations. The results 
of Cox models for the three different levels of severity of 
Table 1  Classification of diabetic foot according to severity level
*Excluding traumatic amputations (ICD-9-CM: 895–897, DRG: 442, 443), or amputation because of lower limb neoplasia (ICD-9-CM: 1707, 
1708, DRG: 213, 408)
**Only in case of selected DRG and ICD-9-CM codes as main diagnosis at discharge: DRG 130, 131, 479, 554 (ICD9: 250, 4402, 7854, 4479, 
44422), DRG 271 (ICD9: 7071, 70707, 70706)
Severity level
Major amputation (DRG: 113, ICD9: 841.3–841.9*)
Minor amputation (DRG: 114, ICD9: 841.1–841.2*)
Diabetic foot without amputation
 Ulcer (ICD9: 707.10–707.19)
 Cellulitis and abscess (ICD9: 681.1, 682.6, 682.7)
 Gangrene (ICD9: 785.4)
 Osteomyelitis (ICD9: 730.07–730.17)
 Necrotizing fasciitis (ICD9: 728.86)
 Angioplasty or atherectomy of other non-coronary vessel(s) (Proc. 
39.50)
 Full-thickness skin graft to other sites (Proc. 86.63–86.66)
Other DRG
 Peripheral vascular disorders with cc (DRG: 130)**
 Peripheral vascular disorders without cc/mcc (DRG: 131)**
 Skin graft for skin ulcer or cellulitis with cc (DRG:263)
 Skin graft for skin ulcer or cellulitis without cc/mcc (DRG:264)
 Other cardiovascular procedures without cc (DRG: 479)**
 Other cardiovascular procedures without major cardiovascular 
diagnosis(DRG: 554)**
 Skin ulcers (DRG: 271)**
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Table 2  Incidence of DF among patients with diabetes in 2012–2016
DF diabetic foot, CVD cardiovascular disease
*Age-adjusted rates × 100,000 and 95% confidence intervals
Men No amputations Minor amputations Major amputations
n Rate [95% CI] n Rate [95% CI] n Rate [95% CI]
All 2667 2178.8 2095.6–2261.9 559 457.1 419.0–495.2 558 466.1 427.2–505.0
Diabetes type
 Type 2 2449 2197.0 2109.4–2284.7 497 454.3 414.2–494.4 495 446.2 406.7–485.6
 Type 1 189 2309.7 1967.8–2651.6 51 550.3 392.7–708.0 54 685.1 493.6–876.6
 Other 49 2193.8 1578.9–2808.7 11 476.6 194.6–758.6 9 418.0 144.7–691.4
Therapy
 None 283 975.8 860.3–1091.3 37 123.6 83.3–163.8 45 138.9 97.7–180.0
 Not secretagogue 799 1589.2 1478.0–1700.5 114 229.8 187.3–272.3 98 205.6 164.6–246.7
 Secretagogue 267 2294.4 2018.5–2570.3 49 431.2 310.2–552.2 41 347.9 241.3–454.6
 Insulin basal/slow acting 245 3671.2 3211.0–4131.4 52 790.8 575.6–1006.0 56 864.5 637.7–1091.3
 Insulin basal + rapid acting 1073 4587.7 4311.4–4863.9 307 1307.3 1159.5–1455.0 318 1404.3 1248.2–1560.3
Previous CVD
 No 2072 1957.7 1873.4–2042.0 442 415.3 376.6–454.1 498 379.2 342.1–416.3
 Yes 595 3930.5 3612.2–4248.9 117 804.1 657.1–951.0 156 1042.3 877.1–1207.5
Previous dialysis
 No 2553 2124.5 2042.2–2206.9 515 428.5 391.5–465.5 509 423.5 386.7–460.3
 Yes 114 14,114.4 11,521–16,708 44 5595.9 3939.4–7252.4 49 6269.4 6269.4–8029.1
Educational level
 Low 1285 2595.4 2448.2–2742.7 304 660.5 581.8–739.3 327 656.9 582.1–731.6
 Medium 868 2308.8 2152.2–2465.3 161 404.4 340.7–468.0 160 429.5 361.7–497.4
 High 420 2098.9 1896.4–2301.4 73 343.1 263.8–422.5 54 268.9 196.7–341.0
 Missing 94 21 17
Women No amputations Minor amputations Major amputations
n Rate* [95% CI] n Rate* [95% CI] n Rate* [95% CI]
All 1683 1352.3 1287.5–1417.1 242 194.3 169.7–218.8 290 228.1 201.8–254.4
Diabetes type
 Type 2 1520 1468.6 1394.5–1542.7 215 208.1 180.2–236.0 266 256.9 225.9–287.8
 Type 1 135 1793.8 1476.2–2111.1 25 326.1 189.9–462.2 21 278.3 154.4–402.2
 Other 28 1590.7 978.7–2202.7 2 119.4 0–285.0 3 192.2 0–409.8
Therapy
 None 182 457.9 390.3–525.4 10 25.2 9.5–41.0 36 85.9 57.4–114.4
 Not secretagogue 474 1074.2 975.6–1172.8 52 116.7 84.5–148.9 57 136.0 100.1–171.8
 Secretagogue 184 1455.4 1243.7–1667.1 17 138.1 72.1–204.1 34 260.4 172.3–348.4
 Insulin basal/slow acting 154 2357.5 1984.0–2731.1 26 400.6 246.0–555.2 28 433.9 272.7–595.1
 Insulin basal + rapid acting 689 3016.7 2790.6–3242.8 137 598.9 498.1–699.7 135 599.0 497.5–700.5
Previous CVD
 No 1417 1217.8 1154.4–1281.3 199 170.7 147.0–194.5 234 201.4 175.6–227.2
 Yes 266 2790.0 2451.5–3128.4 43 460.9 321.4–600.4 56 576.9 424.2–729.6
Previous dialysis
 No 1618 1290.5 1227.6–1353.3 230 183.5 159.7–207.2 267 212.9 187.4–238.4
 Yes 65 12,779.5 9668.1–15,891 12 2322.6 1006.1–3639.1 23 4760.1 2807.9–6712.3
Educational level
 Low 1155 1551.2 1457.6–1644.9 170 237.7 199.6–275.8 200 258.2 221.2–295.2
 Medium 366 1482.3 1324.8–1639.8 49 186.5 132.3–240.7 57 250.7 185.5–318.0
 High 119 1089.3 883.2–1295.4 18 146.6 74.9–218.4 26 263.5 155.9–371.1
 Missing 43 5 7
225Acta Diabetologica (2020) 57:221–228 
1 3
DF are shown in Table 3. Due to the small number of cases, 
diabetes types other than 1 and 2 have been excluded from 
the analysis, while different levels of therapy have been 
grouped in “none”, “oral therapy”, and “insulin”. HRs were 
also adjusted for local health unit of residence of patients to 
take into account the role of geographical variability due to 
different access to specialist care [14]. After the onset of a 
DF complication, mortality was higher in men compared to 
women, being double in case of amputations (both minor 
and major), and increased with increasing age, in particular 
for major amputations: Patients aged 80 or more were more 
than four and a half times likely to die if affected by a major 
amputation than patients below 60 years old. The risk of 
death did not differ by type of diabetes, while was strongly 
associated with the severity of the disease: The risk was 
higher in insulin-treated patients, in those with cardiovas-
cular disease, and in patients undergoing dialytic treatment. 
Educational level was inversely related to mortality, and this 
association was stronger in the more severe levels of the 
complication: Among patients suffering from amputations, 
the risk of death in low-educated patients was nearly double 
than that in high-educated ones.
Discussion
In this study, based on 250,000 individuals with diabe-
tes, we report that the 5-year incidence of hospitalization 
for DF without amputations is 1762 × 100,000 patients, is 
324 × 100,000 patients for hospitalization with major ampu-
tations, and is 343 × 100,000 for hospitalization with minor 
amputations. Patients affected with the more severe stages of 
diabetes as well as those with low education were at higher 
risk within each of the three types of hospitalization.
We also showed that the prognosis after the onset of DF 
complications worsens with the worsening of the severity of 
DF. The risk of death during a mean follow-up of two and a 
half years was about 16% among patients without amputa-
tions, 18% among patients with minor amputations, and 30% 
among those with major amputations. Other than age, the 
Table 3  Mortality of patients 
with incident DF in 2012–2016
HR hazard ratios; 95% CI confidence intervals; HR also adjusted for local health unit of residence; DF dia-
betic foot; CVD cardiovascular disease
No amputations Minor amputations Major amputations
HR [95% CI] HR [95% CI] HR [95% CI]
n = 720 n = 147 n = 254
Gender
 F 1 1 1
 M 1.55 1.44 1.66 2.37 2.01 2.82 1.94 1.66 2.27
Age classes
 0–60 1 1 1
 61–70 1.35 1.21 1.50 0.93 0.74 1.18 1.35 1.00 1.81
 71–80 1.81 1.63 2.02 1.10 0.87 1.40 2.41 1.66 3.49
 80 + 1.92 1.70 2.17 1.25 0.95 1.65 4.69 2.94 7.48
Diabetes type
 Type 2 1 1 1
 Type 1 0.91 0.80 1.04 0.77 0.57 1.03 1.02 0.77 1.36
Therapy
 None 1 1 1
 Oral only 0.98 0.80 1.20 1.52 1.05 2.18 1.07 0.80 1.43
 Insulin 2.76 2.40 3.18 7.37 5.21 10.4 4.58 3.50 6.00
Previous CVD
 No 1 1 1
 Yes 1.72 1.58 1.87 1.50 1.24 1.81 1.97 1.62 2.34
Previous dialysis
 No 1 1 1
 Yes 7.30 6.16 8.65 10.5 7.81 14.2 12.6 9.67 16.5
Educational level
 Low 1 1 1
 Medium 0.94 0.87 1.02 0.65 0.54 0.79 0.78 0.65 0.94
 High 0.85 0.76 0.95 0.56 0.43 0.73 0.54 0.41 0.71
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risk of death was higher in men, in insulin-treated patients, 
in those affected with severe diabetes complications, particu-
larly on dialysis, and in those with lower levels of education.
Even if the comparisons of our data with the other studies 
available in the literature are difficult because of different 
populations, length of observation time, and, for the cases 
of DF without amputations, the paucity of published data, 
our results show lower incidence of DF and higher survival 
than that previously reported by other authors [7, 15–17].
In England, the incidence of amputations in diabetic 
patients from 2007 to 2010 was 2.51 per 1000 persons/year 
with a relative risk of 23.3 compared to non-diabetic subjects 
[18]. The rate of minor amputations in a sample of 1232 
diabetic subjects with DFU from the Eurodiale prospective 
cohort study reaches 18% in a single year of observation, 
with a wide variation from 2.4 to 34% depending on the DF 
center [19]. In Italy, from 2001 to 2010, the standardized 
discharge rate for amputation in the hospitalized diabetic 
population increased from 12 to 13.3 (per 100,000). The 
trend was substantially stable over time, with a slight reduc-
tion in the major amputations and a growing trend in minor 
amputations [20].
In the OECD countries (that included Italy), the amputa-
tion rates in diabetes patients during the period 2000–2011 
underwent a progressive decrease of − 0.27 per 1000.000 
per year [21]. However, surprisingly, in the USA, after 
two decades of decline in non-traumatic lower-extremity 
amputations in adults with diabetes, a reversal in trend was 
observed from 2009. The increase in hospitalizations for 
non-traumatic lower-extremity amputations is driven by a 
62% increment of the rate of minor amputations and a 29% 
of major amputations, particularly in young- and middle-
aged adults [22].
Minor amputations may indicate a better quality of care 
as being an intervention potentially able to prevent from 
major ones and hence to salvage lower extremities.
As stated by Jeffcoate and Harding, amputation is a 
marker not just of disease, but also of disease management 
[15]. In a long follow-up of 82.6 ± 26.5 months, Giurato 
et al. demonstrated that using a limb salvage protocol—
shared by many centers in Italy—is not just a temporary 
solution, but can change the patient’s life, with long-term 
benefits [23].
In our study, in the period 2012–2016, more than 70% 
out of almost 6000 registered admissions for DF were not 
accompanied by a surgical amputation procedure.
It is common in clinical practice to detect repeated hos-
pitalizations for subsequent treatment phases (for example, 
percutaneous revascularization, treatment of infection, surgi-
cal debridement, amputation, aggravation with more proxi-
mal amputation).
Therefore, the hospitalizations without amputation can 
be the result of either effective treatments (medical and 
surgical), conservative choices justified by the general condi-
tions of the patient or decisions taken by the patient himself. 
It could also be the result of hospitalizations that have not 
completed the therapeutic procedure by discharging patients 
simply after stabilization of the clinical picture, and post-
poning amputation to another hospitalization, a conservative 
approach that is not always appropriate.
The high number of hospitalizations without amputa-
tion could probably be reduced, with a decrease in costs 
for the National Health Service, through the full enhance-
ment and/or strengthening of multi-specialist/professional 
human resources dedicated to the problem of DF, but, above 
all, through the application of diagnostic and therapeutic 
flowcharts.
Consistently with other studies [16, 24], our data show 
gender-related differences with an higher incidence of hos-
pitalizations for DF in males.
Type 1 diabetes affected 7.9% of our cohort. Despite the 
differences in the etiopathogenesis, treatment, and duration 
of the disease, the type of diabetes did not seem to influence 
the incidence of hospitalizations.
As far as therapy is concerned, the increase in its com-
plexity from diet to multi-injective basal-bolus therapy, 
theoretically reflecting the complexity and severity of the 
disease, was associated with an higher incidence of hospi-
talizations in both sexes.
Dialysis is known to be an independent risk factor for foot 
ulcer, its healing, and amputation [24, 25]; the increased risk 
of DF in the presence of cardiovascular disease or dialysis 
treatment, therefore, is not surprising, given that these are 
indicators of systemic vascular damage [9, 10]. In Piedmont, 
in line to other studies, the incidence of minor amputations 
in dialyzed patients is tenfold higher in both sexes, while for 
major amputations is tenfold in men and even twenty times 
in women, further confirming the strongly negative effect of 
dialysis on the prognosis of patients with DF [26].
The higher incidence of DF in patients with lower levels 
of education calls into question of the complexity of diabetic 
disease management. In many countries, including Italy, 
unhealthy behavior, non-adherence to treatment, and diffi-
culty in accessing treatment are more frequent in socially 
disadvantaged groups, and therefore, social differences in 
the onset of complications are not a surprise [27, 28].
As for mortality, the risk at 2.5 years from hospitalization 
for DF ranges from 16% in the absence of amputations to 
30% in the presence of greater amputations. Mortality was 
higher for men in all three classes of disease severity, with a 
risk doubled in groups undergoing amputation. Unlike other 
studies, these values are lower than those observed in other 
series of patients with DF [9, 10, 16, 17].
Mortality progressively increases with age in all the 
groups, but the increase is more evident in those with major 
amputations: There, the risk is almost five times higher in 
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subjects aged > 80 years compared to those < 60. Data can 
reflect both a greater severity of the pathology and the choice 
of more definitive surgical procedures in conditions where 
effective walking rehabilitation is not possible (bedridden 
patients, severe obesity, etc.). Minor amputation could select 
patients with a more favorable prognosis in which a more 
conservative choice was made, regardless of age.
As for the incidence, the type of diabetes does not change 
the risk of death, while insulin therapy or previous cardio-
vascular diseases [29] are accompanied by an increased risk 
of mortality in all the three classes.
The risk of death in patients on dialysis who have under-
gone minor and major amputation is ten times higher than 
for non-dialyzed patients, a data higher than that already 
registered in other studies [29, 30].
As with the incidence of DF, high schooling, even if only 
of medium level, has a protective effect against mortality in 
all three classes of severity.
The main strength of our work is that, to our knowledge, 
it is the first population-based study (i.e., not from selected 
clinical cohorts) to report data on incidence of DF by dif-
ferent levels of severity (including patients without amputa-
tions) and their mortality after the onset of the complication.
However, our study has also some limitations: We do not 
have any information about some relevant clinical data as 
HbA1c levels or duration of diabetes, which can be only 
partially approximated by the type of therapy or comorbidi-
ties. Furthermore, data on behavioral risk factors, such as 
body mass index or physical inactivity, are not available 
from administrative database. However, all our analyses 
were either stratified or adjusted for educational level that is 
a reasonable proxy of unhealthy life styles (27). Finally, an 
underestimation of minor amputations is certain, as these are 
often performed in an outpatient setting and therefore not 
recorded as interventions during hospitalization.
Conclusions
Our work confirms that the presence of a DF weighs on 
mortality and highlights the worsening and prognostically 
unfavorable role of cardiovascular disease, dialysis, as well 
as of low social position.
Notably, our study also focuses on hospitalizations with-
out amputation, a quite common condition that has been so 
far not adequately analyzed in the available literature. Future 
studies should better define the meaning of this heterogene-
ous group.
Author contributions ML and GR conceived of and guided the analysis 
and wrote the manuscript. CP and GR conducted the analysis. BF, GC, 
CP and BG contributed to the data collection and reviewed and edited 
the manuscript. ML and GR are the guarantors of this work and, as 
such, had full access to all the data in the study and take responsibil-
ity for the integrity of the data and the accuracy of the data analysis.
Compliance with ethical standards 
Conflict of interest No potential conflicts of interest relevant to this 
article were reported.
Ethical standard This is an observational study and data were col-
lected retrospectively. All data were anonymously linked and no per-
sonal identifiers were available to researchers. No ethical approval was 
required according to Italian law 211/2003, which explains that no 
ethics committee permission is required for this kind of study.
Informed consent Data were drawn from anonymous regional database 
and informed consent was impossible to obtain. According to Italian 
privacy law, no patient’s or relative’s consent is required for large ret-
rospective population-based studies and if data are published only in 
aggregated form.
References
 1. Armstrong DG, Boulton AJ, Bus SA (2017) Diabetic foot ulcers 
and their recurrence. N Engl J Med 376:2367–2375
 2. Abbott CA, Carrington AL, Ashe H et al (2002) The North-West 
Diabetes Foot Care Study: incidence of, and risk factors for, new 
diabetic foot ulceration in a community-based patient cohort. Dia-
bet Med 19:377–384
 3. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y (2017) Global epi-
demiology of diabetic foot ulceration: a systematic review and 
meta-analysis. Ann Med 49:106–116
 4. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ (2006) 
Prediction of diabetic foot ulcer occurrence using commonly 
available clinical information: the Seattle Diabetic Foot Study. 
Diabetes Care 29:1202–1207
 5. Stoekenbroek RM, Lokin JLC, Nielen MM, Stroes ESG, Koele-
may MJW (2017) How common are foot problems among individ-
uals with diabetes? Diabetic foot ulcers in the Dutch population. 
Diabetologia 60:1271–1275
 6. Margolis DJ, Jeffcoate W (2013) Epidemiology of foot ulcera-
tion and amputation: can global variation be explained? Med Clin 
North Am 97:791–805
 7. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist 
J (2005) The global burden of diabetic foot disease. Lancet 
366:1719–1724
 8. Morbach S, Furchert H, Gröblinghoff U et al (2012) Long-term 
prognosis of diabetic foot patients and their limbs: amputation and 
death over the course of a decade. Diabetes Care 35:2021–2027
 9. Iversen MM, Tell GS, Riise T et al (2009) History of foot ulcer 
increases mortality among individuals with diabetes: ten-year 
follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes 
Care 32:2193–2199
 10. Moxey PW, Gogalniceanu P, Hinchliffe RJ et al (2011) Lower 
extremity amputations—a review of global variability in inci-
dence. Diabet Med 28:1144–1153
 11. Gnavi R, Karaghiosoff L, Dalmasso M, Bruno G (2006) Vali-
dazione dell’archivio di esenzione per diabete della Regione Pie-
monte: vantaggi e limiti per un uso epidemiologico. Epidemiol 
Prev 30:59–64
228 Acta Diabetologica (2020) 57:221–228
1 3
 12. Giorda C, Carnà P, Salomone M et al (2018) Ten-year comparative 
analysis of incidence, prognosis and associated factors for dialysis 
and renal transplantation in type 1 and type 2 diabetes versus non-
diabetes. Acta Diabetol 55:733–740
 13. Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ, Schaper NC 
(2016) The 2015 IWGDF guidance documents on prevention and 
management of foot problems in diabetes: development of an 
evidence-based global consensus. Diabetes Metab Res Rev 32:2–6
 14. Giorda C, Petrelli A, Gnavi R, the Regional Board for Diabetes 
Care of Piemonte (2006) The impact of second-level specialised 
care on hospitalisation among persons with diabetes: a multilevel 
population based study. Diabet Med 23:377–383
 15. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 
361:1545–1551
 16. Martins-Mendes D, Monteiro-Soares M, Boyko EJ et al (2014) 
The independent contribution of diabetic foot ulcer on lower 
extremity amputation and mortality risk. J Diabetes Complicat 
28:632–638
 17. Brennan MB, Hessa TM, Bartle B et al (2017) Diabetic foot ulcer 
severity predicts mortality among veterans with type 2 diabetes. J 
Diabetes Complicat 31:556–561
 18. Holman N, Young RJ, Jeffcoate WJ (2012) Variation in the 
recorded incidence of amputation of the lower limb in England. 
Diabetologia 55:1919–1925
 19. van Battum P, Schaper N, Prompers L et al (2011) Differences in 
minor amputation rate in diabetic foot disease throughout Europe 
are in part explained by differences in disease severity at presenta-
tion. Diabet Med 28:199–205
 20. Lombardo FL, Maggini M, De Bellis A, Seghieri G, Anichini R 
(2014) Lower extremity amputations in persons with and without 
diabetes in Italy: 2001–2010. PLoS ONE 9:e86405
 21. Carinci F, Massi Benedetti M, Klazinga NS, Uccioli L (2016) 
Lower extremity amputation rates in people with diabetes as an 
indicator of health systems performance. A critical appraisal 
of the data collection 2000-2011 by the Organization for Eco-
nomic Cooperation and Development (OECD). Acta Diabetol 
53:825–832
 22. Geiss LS, Li Y, Hora I, Albright A, Rolka D, Gregg EW (2019) 
Resurgence of diabetes-related nontraumatic lower-extremity 
amputation in the young and middle-aged adult U.S. population. 
Diabetes Care 42:50–54
 23. Giurato L, Vainieri E, Meloni M et al (2015) Limb salvage in 
patients with diabetes is not a temporary solution but a life chang-
ing procedure. Diabetes Care 38:e156–e157
 24. Pscherer S, Dippel F-W, Lauterbach S, Kostev K (2012) Ampu-
tation rate and risk factors in type 2 patients with diabetic foot 
syndrome under real-life conditions in Germany. Primary Care 
Diabetes 6:241–246
 25. Ndip A, Lavery LA, Boulton AJ (2010) Diabetic foot disease in 
people with advanced nephropathy and those on renal dialysis. 
Curr Diab Rep 10:283–290
 26. Meloni M, Giurato L, Izzo V et al (2016) Long term outcomes of 
diabetic haemodialysis patients with critical limb ischemia and 
foot ulcer. Diabetes Res Clin Pract 116:117–122
 27. Piccinelli C, Carnà P, Stringhini S et al (2018) The contribution 
of behavioural and metabolic risk factors to socioeconomic ine-
qualities in mortality: the Italian Longitudinal Study. Int J Public 
Health 63:325–335
 28. Petrelli A, De Luca G, Landriscina T, Costa G, Gnavi R (2018) 
Effect of socioeconomic status on surgery waiting times and mor-
tality after hip fractures in Italy. J Health Qual 40:209–216
 29. Faglia E, Clerici G, Clerissi J et al (2006) Early and five-year 
amputation and survival rate of diabetic patients with critical limb 
ischemia: data of a cohort study of 564 patients. Eur J Vasc Endo-
vasc Surg 32:484–490
 30. Meloni M, Izzo V, Giurato L, Cervelli V, Gandini R, Uccioli L 
(2018) Impact of heart failure and dialysis in the prognosis of dia-
betic patients with ischemic foot ulcers. J Clin Transl Endocrinol 
11:31–35
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
